Zusammenfassung
Atrial fibrillation (AF) is the most frequent arrhythmia. Its frequency is constantly increasing together with the life span of the general population, since the incidence of AF rises with age. This arrhythmia should not be underestimated, because it leads to a significant increase of mortality [1] and of clinical events with a high medical cost: heart failure and systemic thromboembolism. Hence the rising involvement of health structures in order to manage the arrhythmia and its complications, with the contribution of different medical operators.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Benjamin EJ, Wolf PA, D’Agostino RB et al (1998) Impact of atrial fibrillation on the risk of death. The Framingham heart study. Circulation 98:946–952
Atrial Fibrillation Investigators (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154:1449–1457
Ezekowitz MD, James KE, Nazarian SM et al (1995) Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Circulation 92:2178–2182
Petersen P, Boisen G, Godtfredsen J et al (1989) Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study. Lancet 1:175
The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators (1990) The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 323:1505
Stoke Prevention in Atrial Fibrillation Investigators (1991) Stroke Prevention in Atrial Fibrillation Study: Final results. Circulation 84:527
Connolly SJ, Laupacis A, Gent M et al (1991) Canadian Atrial Fibrillation Anti-Coagulation (CAFA) Study. J Am Coll Cardiol 18:349
Ezekowitz MD, Bridgers SL, James KE et al (1992) Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation (SPINAF). N Engl J Med 327:1406–1412
EAFT (European Atrial Fibrillation Trial) Study Group (1993) Secondary prevention in nonrheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 342:1255
Scardi S, Mazzone C (1997) La profilassi anticoagulante: dai grandi trial alia pratica clinica. G Ital Cardiol 28:171–183
Levine MN, Roaskob G, Landefeld S et al (1998) Haemorrhagic complications of anticoagulant treatment. Chest 114:511–523
Landefeld CS, Beyth RJ (1993) Anticoagulant-related bleeding: clinical epidemiology, prediction and prevention. Am J Med 95:315–328
Palareti G, Leali N, Coccheri S et al (1997) Complicanze emorragiche della terapia anticoagulante orale: risultati dello studio prospettico multicentrico ISCOAT. G Ital Cardiol 27:231–243
Cortellazzo S, Finazzi G, Viero P et al (1993) Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemostasis 69:316–320
Bussey HL, Chiquette E, Amato M (1995) Anticoagulation clinic care versus routine medical care: a review and interim report. J Thomb Thrombolysis 2:315–319
Ansell JE (1998) Anticoagulation management as a risk factor for adverse events: grounds for improvement. J Thromb Thrombolysis 5[Suppl]:S13–S18
Rosendaal FR (1996) The Scylla and Charybdis of oral anticoagulant treatment. N Engl J Med 335:587–589
Saour JN, Sieck JO, Mamo LAR et al (1990) Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med 322:428–432
Leaning KE, Ansell JE (1996) Advances in the monitoring of oral anticoagulation: point-of-care testing, patient self-monitoring, and patient self-management. J Thromb Thrombolysis 3:377–383
Kitchen S, Preston FE (1997) Monitoring oral anticoagulant treatment with the TAS near-patient test system: comparison with conventional thromboplastins. J Clin Pathol 50:951–956
Ansell JE (1999) Empowering patients to monitor and manage oral anticoagulation therapy. J Am Med Assoc 281:182–183
Andrew M, Marzinotto V, Leakar M et al (1997) Home monitoring of pediatric patients. Scientific Symposium: self-management of oral anticoagulation, State of the art, Florence, pp 20–25
Hasenlam M, Knudsen L, Kimose HH et al (1997) Practicability of patient self testing of oral anticoagulation therapy by the international normalized ratio using a portable whole blood monitor. Thrombosis Res 85:77–82
White RH, McCurday SA, Von Marensdorff H et al (1998) Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Ann Intern Med 111:730–737
Ansell JE, Patel N, Ostrovsky D et al (1995) Long-term patient self-management of oral anti coagulation. Arch Intern Med 155:2185–2189
Kaatz SS, White RH, Hill J et al (1995) Accuracy of laboratory and portable monitor international normalized ratio determinations. Comparison with a criterion standard. Arch Intern Med 155:1861–1867
Hasenkam JM, Kimose L, Gronnesby H et al (1997) Self-management of oral anticoagulant therapy after heart valve replacement. Eur J Cardio Thorac Surg 11:935–942
Bernardo A (1992) Home prothrombin estimation. In: Butchart EG, Bodnar E(eds) Thrombosis, embolism and bleeding. ICR, London pp 325–330
Sawicki PT (1999) A structured teaching and self-management program for patients receiving oral anticoagulation. A randomized controlled trial. J Am Med Assoc 281 (2)
Cromheecke ME, Levi M, Colly LP et al (2000) Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 356:97–102
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Italia
About this paper
Cite this paper
Cazzin, R., Serra, P., Lestuzzi, C. (2002). Self-management of Oral Anticoagulants by Patients with Atrial Fibrillation: How Effective and Safe Is It?. In: Raviele, A. (eds) Cardiac Arrhythmias 2001. Springer, Milano. https://doi.org/10.1007/978-88-470-2103-7_67
Download citation
DOI: https://doi.org/10.1007/978-88-470-2103-7_67
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2165-5
Online ISBN: 978-88-470-2103-7
eBook Packages: Springer Book Archive